Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Clin Chim Acta. 2020 Sep 12;510:767–771. doi: 10.1016/j.cca.2020.08.039

Table 2.

ST2 TIA and ST2 ELISA predicting 1-year mortality as a continuous variable in Cox models

ST2 TIA ST2 ELISA

Model HR (95% CI) P value HR (95% CI) P value
ST2 1.33 (1.22, 1.45) <0.001 1.34 (1.22, 1.48) <0.001

ST2 1.25 (1.14, 1.37) <0.001 1.28 (1.15, 1,42) <0.001
MAGGIC 1.11 (1.08, 1.16) <0.001 1.12 (1.07, 1.17) <0.001

ST2 1.16 (1.04, 1.29) 0.008 1.16 (1.03, 1.31) 0.018
MAGGIC 1.07 (1.02, 1.12) <0.001 1.07 (1.02, 1.12) <0.001
NTproBNP 1.74 (1.32, 2.29) <0.001 1.75 (1.32, 2.31) <0.001

ST2 HR is given per 15ng/mL difference in value. NTproBNP HR is per 400 ng/L difference in value. ELISA, enzyme-linked immunosorbent assay; HR, hazard ratio; MAGGIC, Meta-analysis Global Group in Chronic Heart Failure; NTproBNP, N-terminal pro b-type natriuretic peptide; P, p-value; TIA, turbidimetric immunoassay; sST2, soluble suppression tumorigenicity 2